Trials / Completed
CompletedNCT03549429
Tegaderm vs. EyeGard for Eye Protection
A Randomized Control Trial of Tegaderm vs. EyeGard for Eye Protection During General Anesthesia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 159 (actual)
- Sponsor
- Tufts Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study compares TegadermTM and EyeGard® in general anesthesia.
Detailed description
Protective eye tape is used during anesthesia in order to prevent corneal abrasion and other eye injuries. However, there is no single accepted practice of how to protect the eyes during anesthesia, and a variety of different tapes and techniques have been adopted in different institutions. In this study, investigators will compare two tapes, TegadermTM and EyeGard® to determine if one is less likely to cause eyelid irritation in an effort to improve care for future patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Medical tapes: TegadermTM and EyeGard® | TegadermTM and EyeGard® will be placed over patients' eyes during surgery with general anesthesia. |
Timeline
- Start date
- 2018-06-01
- Primary completion
- 2018-07-19
- Completion
- 2018-07-20
- First posted
- 2018-06-08
- Last updated
- 2019-08-29
- Results posted
- 2019-08-20
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03549429. Inclusion in this directory is not an endorsement.